CRO Perspectives on Changes in Rare Disease Studies

In this ISSUE

Brexit Goes from Bad to Worse for Medicines

Hope. The Power for the Rare Disease Journey

Gene Therapy in Rare Diseases: Home and Dosing Site Considerations

Digital Health

Digital Health Merges with Clinical Trial Patient Centricity

At PanAgora's Clinical Trials Patient Experience Summit, three main topics stood out; companies engrained patient centricity guiding principles in their operational models, the new concept of patient connectivity is emerging, and digital health is rapidly gaining ground in clinical trials.
... /Read more/

Expanding patient access to clinical trials is an ongoing challenge. One solution is designed to allow patients with serious and complex diseases to participate in research in the comfort of their own physicians' offices. Read the Applied Clinical Trials interview to learn more from Syneos Health and Elligo Health Research experts talking about their new partnership enabling enhanced access by creating a system of accelerated research (SOAR).

Click Here

The FDA

FDA Seeks Reliable Patient Information to Support Regulatory Decisions

As FDA continues to advance the role of patients in designing clinical trials with meaningful and accurate endpoints, it is seeking more input from stakeholders on how best to identify clinical outcomes most important to patients and caregivers.
... /Read more/

Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
North America: Tuesday, November 13, 2018 at 11am EDT | 10am CDT | 8am PDT

Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
On Demand

Learn More

Calendar

/ Early Clinical Development 11/27-11/29 /

/ Partnerships in Clinical Trials Europe 11/27-11/29 /

/ Clinical Trial Legal and Contracting Forum 12/4-12/5 /

/ Clinical Trial Financial Management Summit 12/5-12/6 /

/ 14th Biosimilars Summit 1/22/19-1/23/19 /

/ Clinical Data Disclosure and Transparency 1/29/19-1/30/19 /

IDENTIFYING NASH PATIENTS: Solutions and Strategies
On Demand

Learn More

Therapeutic Areas

The Status of Ebola Vaccines

Market players working on development of vaccines to fight against the virus are focused on clinical trials and look forward to gaining approval from regulatory bodies.
... /Read more/

The Potential for Disease-Modifying Therapies in Parkinson's Disease
Tuesday, November 13, 2018 at 11am EST|8am PST|4pm GMT|5pm CEST

Rare Disease

CRO Perspectives on Changes in Rare Disease Studies

In this interview, Lisa Dilworth, as VP, Rare and Orphan Diseases at Synteract, will discuss common challenges with rare disease studies, how to encounter them, and how the rare disease space is evolving.
... /Read more/

Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand

Learn More

Q&A

Q&A: Expanding Clinical Research Access

Partnership focuses on integrating research into the care continuum.
... /Read more/

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com

website / blog / advertise / subscribe